Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Topol, Eric
  • Moliterno, D. J.
  • Herrmann, H. C.
  • Powers, E. R.
  • Grines, C. L.
  • Cohen, D. J.
  • Cohen, E. A.
  • Bertrand, M.
  • Neumann, F. J.
  • Stone, G. W.
  • DiBattiste, P. M.
  • Demopoulos, L.
  • TARGET Investigators

publication date

  • June 2001

journal

  • New England Journal of Medicine  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Combined Modality Therapy
  • Coronary Disease
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Hemorrhage
  • Humans
  • Immunoglobulin Fab Fragments
  • Male
  • Middle Aged
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Stents
  • Thrombocytopenia
  • Tyrosine
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0028-4793

Digital Object Identifier (DOI)

  • 10.1056/nejm200106213442502

PubMed ID

  • 11419425
scroll to property group menus

Additional Document Info

start page

  • 1888

end page

  • 1894

volume

  • 344

issue

  • 25

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support